| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.19 | 7e-07 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.29 | 2e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.26 | 3e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.23 | 0.0002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0009 |